A phase 3 trial of empasiprubart in multifocal motor neuropathy
Latest Information Update: 21 Oct 2024
At a glance
- Drugs Empasiprubart (Primary)
- Indications Multifocal motor neuropathy
- Focus Registrational; Therapeutic Use
- 21 Oct 2024 New trial record
- 15 Oct 2024 According to an argenx media release, study will start by the end of 2024.